These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 23583750)

  • 21. Osteocytes but not osteoblasts directly build mineralized bone structures.
    Wang K; Ren Y; Lin S; Jing Y; Ma C; Wang J; Yuan XB; Han X; Zhao H; Wang Z; Zheng M; Xiao Y; Chen L; Olsen BR; Feng JQ
    Int J Biol Sci; 2021; 17(10):2430-2448. PubMed ID: 34326685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes.
    Rhee Y; Lee EY; Lezcano V; Ronda AC; Condon KW; Allen MR; Plotkin LI; Bellido T
    J Biol Chem; 2013 Oct; 288(41):29809-20. PubMed ID: 23963454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted ablation of the PTH/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses.
    Powell WF; Barry KJ; Tulum I; Kobayashi T; Harris SE; Bringhurst FR; Pajevic PD
    J Endocrinol; 2011 Apr; 209(1):21-32. PubMed ID: 21220409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parathyroid hormone signaling in mature osteoblasts/osteocytes protects mice from age-related bone loss.
    Uda Y; Saini V; Petty CA; Alshehri M; Shi C; Spatz JM; Santos R; Newell CM; Huang TY; Kochen A; Kim JW; Constantinou CK; Saito H; Held KD; Hesse E; Pajevic PD
    Aging (Albany NY); 2021 Dec; 13(24):25607-25642. PubMed ID: 34968192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteocytes mediate the anabolic actions of canonical Wnt/β-catenin signaling in bone.
    Tu X; Delgado-Calle J; Condon KW; Maycas M; Zhang H; Carlesso N; Taketo MM; Burr DB; Plotkin LI; Bellido T
    Proc Natl Acad Sci U S A; 2015 Feb; 112(5):E478-86. PubMed ID: 25605937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo.
    Rhee Y; Bivi N; Farrow E; Lezcano V; Plotkin LI; White KE; Bellido T
    Bone; 2011 Oct; 49(4):636-43. PubMed ID: 21726676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of Dkk-1 in Osteocytes Mitigates Alveolar Bone Loss in Mice With Periodontitis.
    Goes P; Dutra C; Lösser L; Hofbauer LC; Rauner M; Thiele S
    Front Immunol; 2019; 10():2924. PubMed ID: 31921182
    [No Abstract]   [Full Text] [Related]  

  • 28. Osteocyte Death and Bone Overgrowth in Mice Lacking Fibroblast Growth Factor Receptors 1 and 2 in Mature Osteoblasts and Osteocytes.
    McKenzie J; Smith C; Karuppaiah K; Langberg J; Silva MJ; Ornitz DM
    J Bone Miner Res; 2019 Sep; 34(9):1660-1675. PubMed ID: 31206783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis.
    Kramer I; Halleux C; Keller H; Pegurri M; Gooi JH; Weber PB; Feng JQ; Bonewald LF; Kneissel M
    Mol Cell Biol; 2010 Jun; 30(12):3071-85. PubMed ID: 20404086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mef2c deletion in osteocytes results in increased bone mass.
    Kramer I; Baertschi S; Halleux C; Keller H; Kneissel M
    J Bone Miner Res; 2012 Feb; 27(2):360-73. PubMed ID: 22161640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
    Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
    Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The YAP/TAZ transcriptional co-activators have opposing effects at different stages of osteoblast differentiation.
    Xiong J; Almeida M; O'Brien CA
    Bone; 2018 Jul; 112():1-9. PubMed ID: 29626544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass.
    Goh BC; Singhal V; Herrera AJ; Tomlinson RE; Kim S; Faugere MC; Germain-Lee EL; Clemens TL; Lee SJ; DiGirolamo DJ
    J Biol Chem; 2017 Aug; 292(33):13809-13822. PubMed ID: 28659341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conditional Deletion of Sost in MSC-Derived Lineages Identifies Specific Cell-Type Contributions to Bone Mass and B-Cell Development.
    Yee CS; Manilay JO; Chang JC; Hum NR; Murugesh DK; Bajwa J; Mendez ME; Economides AE; Horan DJ; Robling AG; Loots GG
    J Bone Miner Res; 2018 Oct; 33(10):1748-1759. PubMed ID: 29750826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of p38α MAPK Signaling in Osteoblast Lineage Cells Impairs Bone Anabolic Action of Parathyroid Hormone.
    Thouverey C; Caverzasio J
    J Bone Miner Res; 2016 May; 31(5):985-93. PubMed ID: 26643857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoblast-specific deletion of Hrpt2/Cdc73 results in high bone mass and increased bone turnover.
    Droscha CJ; Diegel CR; Ethen NJ; Burgers TA; McDonald MJ; Maupin KA; Naidu AS; Wang P; Teh BT; Williams BO
    Bone; 2017 May; 98():68-78. PubMed ID: 28384511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone H3K27 demethylase, Utx, regulates osteoblast-to-osteocyte differentiation.
    Xia Y; Ikedo A; Lee JW; Iimura T; Inoue K; Imai Y
    Biochem Biophys Res Commun; 2022 Jan; 590():132-138. PubMed ID: 34974301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cilia-like structures and polycystin-1 in osteoblasts/osteocytes and associated abnormalities in skeletogenesis and Runx2 expression.
    Xiao Z; Zhang S; Mahlios J; Zhou G; Magenheimer BS; Guo D; Dallas SL; Maser R; Calvet JP; Bonewald L; Quarles LD
    J Biol Chem; 2006 Oct; 281(41):30884-95. PubMed ID: 16905538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
    Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
    J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential responses of mechanosensitive osteocyte proteins in fore- and hindlimbs of hindlimb-unloaded rats.
    Metzger CE; Brezicha JE; Elizondo JP; Narayanan SA; Hogan HA; Bloomfield SA
    Bone; 2017 Dec; 105():26-34. PubMed ID: 28782619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.